Back

Impact of initial rhythm control with cryoballoon ablation versus drug therapy on atrial fibrillation recurrence and quality of life: results from the Cryo-FIRST study

23 April 2021 (14:00 - 15:00)
Organised by:
Congress Presentation Part of: Treatment and prognosis of atrial fibrillation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Nikola Pavlovic

University Hospital Dubrava, Zagreb (Croatia)

5 More presentations in this session

Presentation thumbnail
Early rhythm-control ablation therapy in preventing AF recurrences: insight from the CHARISMA Registry
Doctor L. Segreti (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Prognosis of new-onset of atrial fibrillation in acute coronary syndrome: Portuguese experience
Doctor H. Santos (Lisboa, PT)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of 50-60 Watt high-power short-duration radiofrequency catheter ablation of atrial fibrillation: A propensity score matching study
Doctor J. Park (Yongin, KR)
Abstract Slides Video
Presentation thumbnail
Endocardial left atrial appendage occlusion in atrial fibrillation: computational fluid dynamics simulations to assess stroke risk
Associate Professor C. Corsi (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Left atrial strain imaging evaluation: a strong predictor of atrial fibrillation recurrence after single-procedure catheter ablation
Doctor P. Garcia Bras (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment and prognosis of atrial fibrillation

The Event

Event poster

EHRA 2021

23 April 2021 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources